Karl Fisher determination of residual moisture in veterinary vaccines - Practical implementation in market monitoring

Acta Poloniae Pharmaceutica - Drug Research

Volumn 69, Issue 6, 2012, Pages 1364-1367

  Krasucka, Dorota M ^a   Kos, Katarzyna ^a   Cybulski, Wojciech A ^a   Mitura, Agata ^a   Łysiak, Ewa ^a   Pietroń, Wojciech J ^a  

^a NATIONAL VETERINARY RESEARCH INSTITUTE   (Poland)

Author keywords

Coulometric method; Karl Fisher; Monitoring; Veterinary vaccines

Indexed keywords

DIETHANOLAMINE; IMIDAZOLE; METHANOL; SULFUR DIOXIDE; VACCINE; VETERINARY DRUG;

ARTICLE; ATMOSPHERIC MOISTURE; CAT; COULOMETRY; DOG; DRUG DOSE TITRATION; DRUG MARKETING; DRUG QUALITY; DRUG SURVEILLANCE PROGRAM; HUMIDITY; KARL FISHER METHOD; LYOPHILISATE; NONHUMAN; PRACTICE GUIDELINE; PROCESS OPTIMIZATION; RABBIT; TITRIMETRY;

ANIMALS; CATS; DOGS; RABBITS; VACCINATION; VACCINES; VETERINARY MEDICINE; WATER;

EID: 84870913429     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Zheng Y., Lai X., Wrang Bruun S., Ipsen H.,Nedergaard Larsen J., Lowenstein H., Sondergaard I., Jacobsen S.: J. Pharm. Biomed. Anal. 46, 592 (2008).
2. Towns J.K.: J Chromatogr. A 705, 115 (1995).
3. May J.C., Del Grosso A., Etz N., Wheeler R., Rey L.: J. Therm. Anal. Calorim. 83, 31 (2006).
4. Zheng Y.: Ph.D. Thesis, Analysis of vaccine: Structure, storage, moisture, and classification by infrared technology. Technical University of Denmark, Kongens Lyngby 2006.
5. Code of Federal Regulations, 21CFR 619.13 (a), p. 68, U.S. Government Printing Office, Washington, D.C. 2002.
6. May J.C., Wheeler R.M., Etz N., Del Grosso A.: Developments in Biological Standardization, vol. 74, pp. 153-164, S. Karger, Basel 1991.
7. ndedn., Rey L, May J.C. Eds. pp. 349-384, Marcel Dekker, New York 2004.
8. Pisol S.S., Wawde G.M., Bondivadekar M.M., Hajare A.A., More H.N., Kadam S.S.: Indian J. Biotechnol. 5, 491 (2006).
9. Shahkarami MK, Taqavian M., Shafyi A., Alirezaie B., Esna-ashari F., Soleimani S., Shahbazi R.: Iran. J. Virol. 3, 25 (2009).
10. Maa Y-F., Nguyen P-A., Andya J.D., Dasovich N., Sweeney T.D., Shire S.J., Hsu Ch.C.: Pharm. Res. 15, 5 (1998).
11. Polish Pharmacopoeia 2.5.32. (01/2005:20532), Polish Pharmaceutical Society, Warszawa 2005.